Naoko Takebe to Carcinoma, Endometrioid
This is a "connection" page, showing publications Naoko Takebe has written about Carcinoma, Endometrioid.
Connection Strength
0.126
-
Pharmacodynamic markers and clinical results from the phase 2 study of the SMAC mimetic birinapant in women with relapsed platinum-resistant or -refractory epithelial ovarian cancer. Cancer. 2016 Feb 15; 122(4):588-597.
Score: 0.126